Company Filing History:
Years Active: 2021
Title: Yeon-Sook Yun: Innovator in Angiogenesis and Radiosensitization
Introduction
Yeon-Sook Yun is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of medical science, particularly in the area of angiogenesis and radiosensitization. His innovative work has the potential to impact cancer treatment and improve patient outcomes.
Latest Patents
Yeon-Sook Yun holds a patent for the use of paeonol in inhibiting angiogenesis and enhancing radiosensitization. The patent describes a composition that includes paeonol or its pharmaceutically acceptable salts as an active ingredient. This composition is designed to inhibit angiogenesis or enhance radiosensitization in subjects undergoing radiotherapy. The invention also outlines methods for administering effective amounts of paeonol to achieve these therapeutic effects.
Career Highlights
Throughout his career, Yeon-Sook Yun has worked with notable organizations such as Angiolab, Inc. and the Korea Institute of Radiological & Medical Sciences. His experience in these institutions has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Yeon-Sook Yun has collaborated with colleagues such as Min-Young Kim and Hee-Suk Lee. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Yeon-Sook Yun's contributions to the fields of angiogenesis and radiosensitization highlight his role as an influential inventor. His work continues to pave the way for advancements in cancer treatment and patient care.